Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 494)
Posted On: 10/05/2024 10:39:36 PM
Post# of 154140
Posted By: My69z
Re: My69z #146912
*Citation43
However, the administration of a highly potent antiviral human mAb cocktail to Zika virus-infected pregnant macaques, at the time of peak viremia, was insufficient to block viral replication in the fetal compartment"

*The heightened mAb levels identified in dams and newborns in this study could translate to protection against HIV viral challenges for dams and neonates.

*While our study did not directly test protection against viral challenges, CCR5 blockade by leronlimab does not necessitate additional effector or immune components from the host.

*Ultimately, however, we will evaluate the protection of newborns against viral infection afforded by the in-utero leronlimab-PLS transfer in our follow-up study to confirm treatment efficacy.
___

Functionally controling diseases @ fetus.

No higher calling than that.

Godspeed.













(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site